Reaction
Ventricular Enlargement reporting signals
As of the last recalculation, Ventricular Enlargement appears in 174 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 380.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eplerenone | 33 | 380.2 | 381.2 |
| Torsemide | 36 | 163.7 | 163.8 |
| Nevirapine | 5 | 68.2 | 68.3 |
| Ranolazine | 5 | 59.0 | 59.0 |
| Sacubitril And Valsartan | 27 | 32.8 | 32.8 |